<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26023863</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2015</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.</ArticleTitle><Pagination><StartPage>10636</StartPage><MedlinePgn>10636</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10636</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep10636</ELocationID><Abstract><AbstractText>Human enterovirus 71 (EV71) has become the major pathogen of hand, foot, and mouth disease (HFMD) worldwide, while the anti-EV71 antibody responses other than neutralizing epitopes have not been characterized. In this study, EV71 capsid proteins VP1, VP3, VP0 and various VP1 antigens were constructed to analyze anti-EV71 response in severe HFMD cases, non-HFMD outpatient children and normal adults using a novel evolved immunoglobulin-binding molecule (NEIBM)-based ELISA. The high prevalence of antibody responses against all three capsid proteins was demonstrated, and anti-EV71 VP1 showed the main antibody response. Anti-EV71 VP1 antibody response was found to predominantly target to epitopes based on the common enterovirus cross-reactive sequence. Moreover, inhibition pattern against anti-EV71 VP1 reactions in three groups was obviously different. Taken together, these results firstly characterized the anti-EV71 antibody responses which are predominantly against VP1 epitopes based on common enterovirus cross-reactive sequence. This finding could be helpful for the better understanding of anti-EV71 humoral immunity and useful for seroepidemiological surveillance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuguang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of pediatrics, Wuxi people's hospital, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Baohua</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Blood Transfusion, Changhai Hospital, Second Military Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guorong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Wuxi people's hospital, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jiaojiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiangyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Mingmei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26023863</ArticleId><ArticleId IdType="pmc">PMC4448526</ArticleId><ArticleId IdType="doi">10.1038/srep10636</ArticleId><ArticleId IdType="pii">10.1038/srep10636</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown B. A. &amp; Pallansch M. A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39, 195&#x2013;205 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Kiang D., Smith D. J. &amp; Wang J. R. Evolution of re-emergent virus and its impact on enterovirus 71 epidemics. Exp. Biol. Med. (Maywood) 236, 899&#x2013;908, 10.1258/ebm.2010.010233 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2010.010233</ArticleId><ArticleId IdType="pubmed">21715436</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L. &amp; Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect Dis. 32, 236&#x2013;242, 10.1086/318454 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol. 7, 868&#x2013;869, 10.1016/s1474-4422(08)70207-2 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(08)70207-2</ArticleId><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q. &amp; Wang Z. Epidemiology of Hand, Foot, and Mouth Disease in China, 2008. Disease Surveillance 25, 181&#x2013;184 (2010).</Citation></Reference><Reference><Citation>Schmidt N. J., Lennette E. H. &amp; Ho H. H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129, 304&#x2013;309 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J. et al. Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet 2, 112 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4136956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takatsy S., Kukan E., Mihaly I. &amp; Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 71, 217&#x2013;227 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda G. M., Chang W. K., Yeung C. Y. &amp; Tang P. S. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J. 6, 206&#x2013;208 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L. M. et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 23, 284&#x2013;295 (1979).</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva E. E., Winkler M. T. &amp; Pallansch M. A. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg. Infect Dis. 2, 231&#x2013;233, 10.3201/eid0203.960312 (1996).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0203.960312</ArticleId><ArticleId IdType="pmc">PMC2626804</ArticleId><ArticleId IdType="pubmed">8903236</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F. et al. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J Clin Microbiol 47, 2351-2352 , 10.1128/jcm.00563-09 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 7, 94, 10.1186/1743-422x-7-94 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X. et al. The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6, e25662, 10.1371/journal.pone.0025662 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025662</ArticleId><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. Y. et al. Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010. PLoS One 6, e25287, 10.1371/journal.pone.0025287 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025287</ArticleId><ArticleId IdType="pmc">PMC3182205</ArticleId><ArticleId IdType="pubmed">21980416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F. C. et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7, e37206, 10.1371/journal.pone.0037206 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037206</ArticleId><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S. T. et al. Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg. Infect Dis. 15, 581&#x2013;584, 10.3201/eid1504.081550 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1504.081550</ArticleId><ArticleId IdType="pmc">PMC2671432</ArticleId><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran C. B. et al. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS One 6, e21116, 10.1371/journal.pone.0021116 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021116</ArticleId><ArticleId IdType="pmc">PMC3134465</ArticleId><ArticleId IdType="pubmed">21765891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H. et al. Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China. Virol J. 9, 248, 10.1186/1743-422x-9-248 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-9-248</ArticleId><ArticleId IdType="pmc">PMC3545860</ArticleId><ArticleId IdType="pubmed">23102275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L. W. et al. The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect Dis. 11, 270, 10.1186/1471-2334-11-270 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-11-270</ArticleId><ArticleId IdType="pmc">PMC3198955</ArticleId><ArticleId IdType="pubmed">21988931</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H. et al. Prevalence of antibodies against enterovirus 71 in children from Lu&#x2019;an City in Central China. Jpn. J. Infect Dis. 64, 528&#x2013;532 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22116336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Deng C., Wan J., Zhu L. &amp; Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J. 8, 306, 10.1186/1743-422x-8-306 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-8-306</ArticleId><ArticleId IdType="pmc">PMC3142239</ArticleId><ArticleId IdType="pubmed">21679417</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J. &amp; Rossmann M. G. Crystal structure of human enterovirus 71. Science 336, 1274, 10.1126/science.1218713 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente J. O. et al. Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol 87, 7637&#x2013;7645, 10.1128/jvi.03519-12 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03519-12</ArticleId><ArticleId IdType="pmc">PMC3700288</ArticleId><ArticleId IdType="pubmed">23637404</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J. &amp; Rossmann M. G. Structure determination of enterovirus 71. Acta Crystallogr D Biol Crystallogr 68, 1217&#x2013;1222, 10.1107/s0907444912025772 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/s0907444912025772</ArticleId><ArticleId IdType="pmc">PMC3489104</ArticleId><ArticleId IdType="pubmed">22948923</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang H., Shih S. R., Chen T. C. &amp; Li M. L. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. Curr Med Chem 14, 847&#x2013;856 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17430140</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton J. L., Cornell C. T. &amp; Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3, 765&#x2013;776, 10.1038/nrmicro1284 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1284</ArticleId><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S. et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15, 798&#x2013;801, 10.1038/nm.1992 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y. Y., Chen Y. C. &amp; Lin T. H. Structure of the virus capsid protein VP1 of enterovirus 71 predicted by some homology modeling and molecular docking studies. J. Comput Chem. 27, 1556&#x2013;1570, 10.1002/jcc.20460 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20460</ArticleId><ArticleId IdType="pubmed">16868986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry E. E. et al. Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J. Gen. Virol 86, 1909&#x2013;1920, 10.1099/vir.0.80730-0 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80730-0</ArticleId><ArticleId IdType="pubmed">15958669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry E. et al. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7, 1527&#x2013;1538 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct Mol. Biol. 19, 424&#x2013;429, 10.1038/nsmb.2255 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo D. G. et al. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125, 61&#x2013;68, 10.1016/j.virusres.2006.12.005 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.12.005</ArticleId><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K. et al. Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach. Vaccine 30, 7105&#x2013;7110, 10.1016/j.vaccine.2012.09.030 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.09.030</ArticleId><ArticleId IdType="pubmed">23022400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. C. et al. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 29, 4362&#x2013;4372, 10.1016/j.vaccine.2011.04.010 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T. K., Jia Q., Meng T., Chow V. T. &amp; Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved &#x201c;knob&#x201d; region of VP3 protein. PLoS Negl. Trop. Dis. 8, e2895, 10.1371/journal.pntd.0002895 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X. et al. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J. Virol. 88, 72&#x2013;81, 10.1128/jvi.01848-13 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01848-13</ArticleId><ArticleId IdType="pmc">PMC3911748</ArticleId><ArticleId IdType="pubmed">24131712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H. et al. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J. Virol 87, 11363&#x2013;11370, 10.1128/jvi.01926-13 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01926-13</ArticleId><ArticleId IdType="pmc">PMC3807339</ArticleId><ArticleId IdType="pubmed">23946455</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L. et al. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics 4, 498&#x2013;513, 10.7150/thno.7457 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.7457</ArticleId><ArticleId IdType="pmc">PMC3964443</ArticleId><ArticleId IdType="pubmed">24669278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J. et al. Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One 6, e18477, 10.1371/journal.pone.0018477 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018477</ArticleId><ArticleId IdType="pmc">PMC3077374</ArticleId><ArticleId IdType="pubmed">21533225</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q. et al. Characterization of Tat Antibody Responses in Chinese Individuals Infected with HIV-1. PLoS One 8, e60825, 10.1371/journal.pone.0060825 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060825</ArticleId><ArticleId IdType="pmc">PMC3614898</ArticleId><ArticleId IdType="pubmed">23565278</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S. H. et al. Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab. DNA Cell Biol. 27, 423&#x2013;431, 10.1089/dna.2007.0708 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2007.0708</ArticleId><ArticleId IdType="pubmed">18694300</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., Johansson B., Wahren B. &amp; Sallberg M. Molecular basis for serological cross-reactivity between enteroviruses. Clin. Diagn Lab Immunol. 1, 336&#x2013;341 (1994).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC368258</ArticleId><ArticleId IdType="pubmed">7496972</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M. S., Maher K., Kilpatrick D. R. &amp; Pallansch M. A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol 73, 1941&#x2013;1948 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda N., Tanimura M. &amp; Miyamura K. Molecular evolution of the major capsid protein VP1 of enterovirus 70. J. Virol 68, 854&#x2013;862 (1994).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236522</ArticleId><ArticleId IdType="pubmed">8289388</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. et al. Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol. 11, 246, 10.1186/1471-2180-11-246 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-11-246</ArticleId><ArticleId IdType="pmc">PMC3217892</ArticleId><ArticleId IdType="pubmed">22050722</ArticleId></ArticleIdList></Reference><Reference><Citation>Halim S. &amp; Ramsingh A. I. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 269, 86&#x2013;94, 10.1006/viro.2000.0188 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0188</ArticleId><ArticleId IdType="pubmed">10725201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. N. et al. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20, 895&#x2013;904 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A. C. et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324, 55&#x2013;59, 10.1126/science.1165557 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165557</ArticleId><ArticleId IdType="pmc">PMC3923423</ArticleId><ArticleId IdType="pubmed">19213880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford R. M. et al. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J. Virol 78, 3663&#x2013;3674 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC371056</ArticleId><ArticleId IdType="pubmed">15016887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Dong M., Jiang B., Dai X. &amp; Meng J. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71. Virus Res. 167, 337&#x2013;342, 10.1016/j.virusres.2012.05.019 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.05.019</ArticleId><ArticleId IdType="pubmed">22659489</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F. et al. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One 5, e11388, 10.1371/journal.pone.0011388 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011388</ArticleId><ArticleId IdType="pmc">PMC2894942</ArticleId><ArticleId IdType="pubmed">20613983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P. et al. A simple, universal, efficient PCR-based gene synthesis method: Sequential OE-PCR gene synthesis. Gene , 10.1016/j.gene.2013.03.126 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.03.126</ArticleId><ArticleId IdType="pubmed">23597923</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W. et al. A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies. Vaccine 30, 2453&#x2013;2461, 10.1016/j.vaccine.2012.01.055 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.01.055</ArticleId><ArticleId IdType="pubmed">22330127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mythili T., Rajendra L., Bhavesh T., Thiagarajan D. &amp; Srinivasan V. A. Development and comparative evaluation of a competitive ELISA with rose bengal test and a commercial indirect ELISA for serological diagnosis of brucellosis. Indian J. Microbiol. 51, 528&#x2013;530, 10.1007/s12088-011-0151-0 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12088-011-0151-0</ArticleId><ArticleId IdType="pmc">PMC3209930</ArticleId><ArticleId IdType="pubmed">23024418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota J., Shimoji Y. &amp; Shimizu S. New sensitive competitive enzyme-linked immunosorbent assay using a monoclonal antibody against nonstructural protein 1 of West Nile virus NY99. Clin. Vaccine Immunol. 19, 277&#x2013;283, 10.1128/cvi.05382-11 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cvi.05382-11</ArticleId><ArticleId IdType="pmc">PMC3272939</ArticleId><ArticleId IdType="pubmed">22190400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N. et al. Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay. Clin. Vaccine Immunol. 20, 9&#x2013;16, 10.1128/cvi.00516-12 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cvi.00516-12</ArticleId><ArticleId IdType="pmc">PMC3535769</ArticleId><ArticleId IdType="pubmed">23114700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>